Karen Snyder

Pharmacokinetics and pharmacodynamics of sitagliptin, an inhibitor of dipeptidyl peptidase IV, in healthy subjects: Results from two randomized, double-blind, placebo-controlled studies with single oral doses

Gary Herman, C. Melinda Stevens, Koen Vandyck et al. · Clinical Pharmacology & Therapeutics · 2005 · 514 citations

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Gary Herman, Arthur Bergman, Catherine Stevens et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 498 citations

Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: A double-blind, randomized, placebo-controlled study in healthy male volunteers

Arthur Bergman, Catherine Stevens, Yanyan Zhou et al. · Clinical Therapeutics · 2006 · 265 citations

Pharmacological Study, Medicine, Healthy Male Volunteers +5

Pharmacokinetics and Pharmacodynamic Effects of the Oral DPP‐4 Inhibitor Sitagliptin in Middle‐Aged Obese Subjects

Gary Herman, Arthur Bergman, Fang Liu et al. · The Journal of Clinical Pharmacology · 2006 · 184 citations

Middle‐aged Obese Subjects, Pharmacotherapy, Insulin Signaling +16

Efficacy and Safety of Intranasal Peptide YY3–36 for Weight Reduction in Obese Adults

Ira Gantz, Ngozi Erondu, Madhuja Mallick et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 160 citations · Full text